Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas

L. Castagna, A. Bertuzzi, A. Nozza, L. Siracusano, M. Balzarotti, M. Magagnoli, B. Sarina, I. Timofeeva, M. Sinnone, M. G. Grimoldi, M. Farè, A. Santoro

Research output: Contribution to journalArticle

Abstract

The aim of this pilot study was to exploit the graft-versus-tumor potential of allogeneic transplants while improving safety of the procedure. Twelve patients with advanced hematological malignancies and solid tumors underwent a low intensity conditioning regimen (fludarabine and cyclophosphamide) followed by an allogeneic peripheral blood stem cell transplantation. The median time to achieve an absolute neutrophil count of more than 0.5 × 109/1 and an untransfused platelet count of more than 20 × 109/1 was 15 and 14 days, respectively. The main extra-hematological toxicities were mucositis and infections. Acute graft-versus-host (GVHD) disease was experienced by 62% of evaluable patients (grade II/B or III/C 80%) responsive to steroids. Extensive chronic GVHD was observed in 62% of patients. Non-relapse transplant-related mortality by day +30 was observed in three patients (25 %). Eight out of 12 patients were full donor chimeric by day +100. One patient showed a mixed chimerism at day +37 when he died from progressive disease. One patient was in complete remission (CR) before allogeneic transplantation, and after transplantation four patients achieved CR and four experienced progressive disease. Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients.

Original languageEnglish
Pages (from-to)207-214
Number of pages8
JournalBone Marrow Transplantation
Volume30
Issue number4
DOIs
Publication statusPublished - Aug 2002

Fingerprint

Granulocyte Colony-Stimulating Factor
Lymphoma
Neoplasms
Transplants
Peripheral Blood Stem Cell Transplantation
Chimerism
Mucositis
Homologous Transplantation
Stem Cell Transplantation
Graft vs Host Disease
Hematologic Neoplasms
Platelet Count
Cyclophosphamide
Neutrophils
Transplantation
Steroids
Tissue Donors
Safety
Mortality
Infection

Keywords

  • Allogeneic transplantation
  • Immunotherapy
  • Low intensity conditioning regimen

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. / Castagna, L.; Bertuzzi, A.; Nozza, A.; Siracusano, L.; Balzarotti, M.; Magagnoli, M.; Sarina, B.; Timofeeva, I.; Sinnone, M.; Grimoldi, M. G.; Farè, M.; Santoro, A.

In: Bone Marrow Transplantation, Vol. 30, No. 4, 08.2002, p. 207-214.

Research output: Contribution to journalArticle

@article{7606f81605d24107946a6b1d177bae4f,
title = "Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas",
abstract = "The aim of this pilot study was to exploit the graft-versus-tumor potential of allogeneic transplants while improving safety of the procedure. Twelve patients with advanced hematological malignancies and solid tumors underwent a low intensity conditioning regimen (fludarabine and cyclophosphamide) followed by an allogeneic peripheral blood stem cell transplantation. The median time to achieve an absolute neutrophil count of more than 0.5 × 109/1 and an untransfused platelet count of more than 20 × 109/1 was 15 and 14 days, respectively. The main extra-hematological toxicities were mucositis and infections. Acute graft-versus-host (GVHD) disease was experienced by 62{\%} of evaluable patients (grade II/B or III/C 80{\%}) responsive to steroids. Extensive chronic GVHD was observed in 62{\%} of patients. Non-relapse transplant-related mortality by day +30 was observed in three patients (25 {\%}). Eight out of 12 patients were full donor chimeric by day +100. One patient showed a mixed chimerism at day +37 when he died from progressive disease. One patient was in complete remission (CR) before allogeneic transplantation, and after transplantation four patients achieved CR and four experienced progressive disease. Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients.",
keywords = "Allogeneic transplantation, Immunotherapy, Low intensity conditioning regimen",
author = "L. Castagna and A. Bertuzzi and A. Nozza and L. Siracusano and M. Balzarotti and M. Magagnoli and B. Sarina and I. Timofeeva and M. Sinnone and Grimoldi, {M. G.} and M. Far{\`e} and A. Santoro",
year = "2002",
month = "8",
doi = "10.1038/sj.bmt.1703626",
language = "English",
volume = "30",
pages = "207--214",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas

AU - Castagna, L.

AU - Bertuzzi, A.

AU - Nozza, A.

AU - Siracusano, L.

AU - Balzarotti, M.

AU - Magagnoli, M.

AU - Sarina, B.

AU - Timofeeva, I.

AU - Sinnone, M.

AU - Grimoldi, M. G.

AU - Farè, M.

AU - Santoro, A.

PY - 2002/8

Y1 - 2002/8

N2 - The aim of this pilot study was to exploit the graft-versus-tumor potential of allogeneic transplants while improving safety of the procedure. Twelve patients with advanced hematological malignancies and solid tumors underwent a low intensity conditioning regimen (fludarabine and cyclophosphamide) followed by an allogeneic peripheral blood stem cell transplantation. The median time to achieve an absolute neutrophil count of more than 0.5 × 109/1 and an untransfused platelet count of more than 20 × 109/1 was 15 and 14 days, respectively. The main extra-hematological toxicities were mucositis and infections. Acute graft-versus-host (GVHD) disease was experienced by 62% of evaluable patients (grade II/B or III/C 80%) responsive to steroids. Extensive chronic GVHD was observed in 62% of patients. Non-relapse transplant-related mortality by day +30 was observed in three patients (25 %). Eight out of 12 patients were full donor chimeric by day +100. One patient showed a mixed chimerism at day +37 when he died from progressive disease. One patient was in complete remission (CR) before allogeneic transplantation, and after transplantation four patients achieved CR and four experienced progressive disease. Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients.

AB - The aim of this pilot study was to exploit the graft-versus-tumor potential of allogeneic transplants while improving safety of the procedure. Twelve patients with advanced hematological malignancies and solid tumors underwent a low intensity conditioning regimen (fludarabine and cyclophosphamide) followed by an allogeneic peripheral blood stem cell transplantation. The median time to achieve an absolute neutrophil count of more than 0.5 × 109/1 and an untransfused platelet count of more than 20 × 109/1 was 15 and 14 days, respectively. The main extra-hematological toxicities were mucositis and infections. Acute graft-versus-host (GVHD) disease was experienced by 62% of evaluable patients (grade II/B or III/C 80%) responsive to steroids. Extensive chronic GVHD was observed in 62% of patients. Non-relapse transplant-related mortality by day +30 was observed in three patients (25 %). Eight out of 12 patients were full donor chimeric by day +100. One patient showed a mixed chimerism at day +37 when he died from progressive disease. One patient was in complete remission (CR) before allogeneic transplantation, and after transplantation four patients achieved CR and four experienced progressive disease. Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients.

KW - Allogeneic transplantation

KW - Immunotherapy

KW - Low intensity conditioning regimen

UR - http://www.scopus.com/inward/record.url?scp=0036672762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036672762&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703626

DO - 10.1038/sj.bmt.1703626

M3 - Article

C2 - 12203136

AN - SCOPUS:0036672762

VL - 30

SP - 207

EP - 214

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -